Yuejun Liu
About
In The Last Decade
Yuejun Liu
22 papers receiving 325 citations
Peers
Comparison fields: 5 of 69
- Materials Chemistry 106
- Molecular Biology 102
- Biomedical Engineering 68
- Cancer Research 66
- Biomaterials 46
Countries citing papers authored by Yuejun Liu
This map shows the geographic impact of Yuejun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuejun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuejun Liu more than expected).
Fields of papers citing papers by Yuejun Liu
This network shows the impact of papers produced by Yuejun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuejun Liu. The network helps show where Yuejun Liu may publish in the future.
Co-authorship network of co-authors of Yuejun Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Yuejun Liu. A scholar is included among the top collaborators of Yuejun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuejun Liu. Yuejun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 4 | |
| 6 | 0 | |
| 7 | 6 | |
| 8 | 2 | |
| 9 | 7 | |
| 10 | 12 | |
| 11 | 31 | |
| 12 | 33 | |
| 13 | 14 | |
| 14 | 14 | |
| 15 | 70 | |
| 16 | 3 | |
| 17 | 37 | |
| 18 | 27 | |
| 19 | [Clinical and laboratory features of patients with CD34(+) acute promyelocytic leukemia]. | 1 |
| 20 | [Prevalence and clinical significance of FLT3 mutations in acute promyelocytic leukemia]. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.